*SURMOUNT-5 was a 72-week, Phase 3b, multicenter, randomized, parallel-arm, open-label, comparator-controlled study that evaluated the efficacy and safety of Tirzepatide 15 mg or MTD (10 mg or 15 mg) compared with Semaglutide 2.4 mg or MTD (1.7 mg or 2.4 mg) in adults with Obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one Obesity-related complication (e.g., hypertension, dyslipidemia), excluding diabetes.** The study included a 2-week screening period
doi: 10.3389/fimmu.2023.1181156 58 HuZChenLZhaoJZhangWJinZSunYet al
Every process in your body that keeps you moving, thinking, and breathing runs, at the most basic level, on the flow of electrons whether that's giving, taking, or sharing electrons
May your peptides stay pure, your storage stay cold, and your research stay rigorous.